Prakash K. Bhuyan, Michael Dallas, Kim Kraynyak, Timothy Herring, Matthew Morrow, Jean Boyer, . . . David B. Weiner. (2021). Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL. Taylor & Francis Group.
Chicago Style (17th ed.) CitationPrakash K. Bhuyan, Michael Dallas, Kim Kraynyak, Timothy Herring, Matthew Morrow, Jean Boyer, Susan Duff, Joseph Kim, and David B. Weiner. Durability of Response to VGX-3100 Treatment of HPV16/18 Positive Cervical HSIL. Taylor & Francis Group, 2021.
MLA (9th ed.) CitationPrakash K. Bhuyan, et al. Durability of Response to VGX-3100 Treatment of HPV16/18 Positive Cervical HSIL. Taylor & Francis Group, 2021.
Warning: These citations may not always be 100% accurate.